Ulus Atasoy

2.5k total citations
43 papers, 2.1k citations indexed

About

Ulus Atasoy is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ulus Atasoy has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 15 papers in Immunology and 7 papers in Cancer Research. Recurrent topics in Ulus Atasoy's work include RNA Research and Splicing (27 papers), RNA and protein synthesis mechanisms (14 papers) and RNA modifications and cancer (12 papers). Ulus Atasoy is often cited by papers focused on RNA Research and Splicing (27 papers), RNA and protein synthesis mechanisms (14 papers) and RNA modifications and cancer (12 papers). Ulus Atasoy collaborates with scholars based in United States, Australia and Italy. Ulus Atasoy's co-authors include Myriam Gorospe, Jack D. Keene, Wenyi Qin, Weizhu Zhu, Edward R. Sauter, Isabel López de Silanes, Jennifer L. Martindale, Cristiana Stellato, Krystyna Mazan-Mamczarz and Stefanie Galbán and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Ulus Atasoy

41 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulus Atasoy United States 22 1.6k 732 438 277 149 43 2.1k
Jens Bo Hansen Denmark 12 1.2k 0.7× 684 0.9× 228 0.5× 137 0.5× 83 0.6× 17 1.6k
Catherine Labbaye Italy 22 1.6k 1.0× 1.3k 1.7× 389 0.9× 176 0.6× 138 0.9× 38 2.3k
Stefania Dell’Orso United States 18 1.8k 1.1× 511 0.7× 421 1.0× 426 1.5× 220 1.5× 37 2.4k
Heide Christine Patterson United States 11 1.7k 1.1× 1.5k 2.0× 588 1.3× 170 0.6× 255 1.7× 13 2.5k
Florence Schaffner United States 22 1.1k 0.7× 305 0.4× 270 0.6× 338 1.2× 94 0.6× 26 2.1k
Eleonora Leucci Italy 24 1.4k 0.9× 1.1k 1.5× 180 0.4× 364 1.3× 69 0.5× 47 2.0k
Timur R. Samatov Russia 20 1.0k 0.6× 688 0.9× 135 0.3× 176 0.6× 69 0.5× 34 1.4k
Kristin F. Wilson United States 21 1.3k 0.8× 591 0.8× 131 0.3× 199 0.7× 87 0.6× 30 1.8k
Sailaja Narravula United States 6 823 0.5× 363 0.5× 215 0.5× 124 0.4× 145 1.0× 8 1.4k
Takashi Sonoki Japan 18 649 0.4× 227 0.3× 410 0.9× 342 1.2× 261 1.8× 98 1.6k

Countries citing papers authored by Ulus Atasoy

Since Specialization
Citations

This map shows the geographic impact of Ulus Atasoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulus Atasoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulus Atasoy more than expected).

Fields of papers citing papers by Ulus Atasoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulus Atasoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulus Atasoy. The network helps show where Ulus Atasoy may publish in the future.

Co-authorship network of co-authors of Ulus Atasoy

This figure shows the co-authorship network connecting the top 25 collaborators of Ulus Atasoy. A scholar is included among the top collaborators of Ulus Atasoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulus Atasoy. Ulus Atasoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fattahi, Fatemeh, et al.. (2025). HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype. Frontiers in Immunology. 16. 1618677–1618677.
2.
Chen, Jing, et al.. (2017). Interaction of RNA-binding protein HuR and miR-466i regulates GM-CSF expression. Scientific Reports. 7(1). 17233–17233. 20 indexed citations
3.
Chen, Jing, Jennifer L. Martindale, Carole L. Cramer, et al.. (2017). The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells. Journal of Biological Chemistry. 292(35). 14532–14543. 27 indexed citations
4.
Glascock, Jacqueline, et al.. (2016). The RNA binding protein HuR is necessary for IL-2 homeostasis and CD4+ T cell differentiation. The Journal of Immunology. 196(1_Supplement). 127.7–127.7. 1 indexed citations
5.
Atasoy, Ulus, et al.. (2016). RNA-Binding Protein Hur Regulates CD4+ T Cell Differentiation and Is Required for Normal IL-2 Homeostasis and Allergic Airway Inflammation. Journal of Allergy and Clinical Immunology. 137(2). AB175–AB175. 1 indexed citations
6.
Davis, J. Wade, et al.. (2015). Transcriptomic-Wide Discovery of Direct and Indirect HuR RNA Targets in Activated CD4+ T Cells. PLoS ONE. 10(7). e0129321–e0129321. 12 indexed citations
7.
Gubin, Matthew M., Joseph Magee, Robert Calaluce, et al.. (2014). Conditional Knockout of the RNA-Binding Protein HuR in CD4+ T Cells Reveals a Gene Dosage Effect on Cytokine Production. Molecular Medicine. 20(1). 93–108. 32 indexed citations
8.
Chen, Jing, Joseph Magee, Matthew M. Gubin, et al.. (2013). Posttranscriptional Gene Regulation of IL-17 by the RNA-Binding Protein HuR Is Required for Initiation of Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 191(11). 5441–5450. 70 indexed citations
9.
Calaluce, Robert, J. Wade Davis, Sharon L. Bachman, et al.. (2012). Incisional hernia recurrence through genomic profiling: a pilot study. Hernia. 17(2). 193–202. 26 indexed citations
10.
11.
Calaluce, Robert, Matthew M. Gubin, J. Wade Davis, et al.. (2010). The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer. BMC Cancer. 10(1). 126–126. 51 indexed citations
12.
Zhu, Weizhu, Wenyi Qin, Ulus Atasoy, & Edward R. Sauter. (2009). Circulating microRNAs in breast cancer and healthy subjects. BMC Research Notes. 2(1). 89–89. 300 indexed citations
13.
Ishmael, Faoud T., Xi Fang, Maria Rosaria Galdiero, et al.. (2008). Role of the RNA-Binding Protein Tristetraprolin in Glucocorticoid-Mediated Gene Regulation. The Journal of Immunology. 180(12). 8342–8353. 81 indexed citations
14.
Qin, Wenyi, Weizhu Zhu, Timothy S. Loy, et al.. (2007). Increased expression of the inflammatory protein YKL‐40 in precancers of the breast. International Journal of Cancer. 121(7). 1536–1542. 19 indexed citations
15.
Gantt, Kira R., et al.. (2006). The regulation of glucose transporter (GLUT1) expression by the RNA binding protein HuR. Journal of Cellular Biochemistry. 99(2). 565–574. 26 indexed citations
16.
Fan, Jinshui, Nicola Heller, Myriam Gorospe, Ulus Atasoy, & Cristiana Stellato. (2005). The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy. European Respiratory Journal. 26(5). 933–947. 83 indexed citations
17.
Atasoy, Ulus, Stephanie Curry, Isabel López de Silanes, et al.. (2003). Regulation of Eotaxin Gene Expression by TNF-α and IL-4 Through mRNA Stabilization: Involvement of the RNA-Binding Protein HuR. The Journal of Immunology. 171(8). 4369–4378. 106 indexed citations
18.
Tenenbaum, Scott A., Craig C. Carson, Ulus Atasoy, & Jack D. Keene. (2003). Genome-wide regulatory analysis using en masse nuclear run-ons emRUNs and ribonomic profiling with autoimmune sera. Gene. 317(1-2). 79–87. 26 indexed citations
19.
Atasoy, Ulus, et al.. (1993). A missense mutation in exon 4 of the human adenosine deaminase gene causes severe combined immunodeficiency. Human Molecular Genetics. 2(8). 1307–1308. 4 indexed citations
20.
Atasoy, Ulus, et al.. (1992). Derivation of a monoclonal anti-murine IL-4 antibody specific for an epitope expressed on denatured molecules. Cytokine. 4(6). 537–544. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jens Bo Hansen Breakdown of academic impact, for papers by Catherine Labbaye Breakdown of academic impact, for papers by Stefania Dell’Orso Breakdown of academic impact, for papers by Heide Christine Patterson Breakdown of academic impact, for papers by Florence Schaffner Breakdown of academic impact, for papers by Eleonora Leucci Breakdown of academic impact, for papers by Timur R. Samatov Breakdown of academic impact, for papers by Kristin F. Wilson Breakdown of academic impact, for papers by Sailaja Narravula Breakdown of academic impact, for papers by Takashi Sonoki
Rankless by CCL
2026